MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guillon, G.
Right arrow Articles by Rajerison, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guillon, G.
Right arrow Articles by Rajerison, R.

Evidence for two molecular forms of solubilized vasopressin receptors in rat kidney membranes. Regulation by guanyl nucleotides

G Guillon, D Butlen and R Rajerison

As previously reported, it is possible to solubilize vasopressin- receptor complexes formed in rat kidney membranes by the use of Triton X-100. Ultracentrifugation on sucrose gradients and elution through molecular sieving columns of these soluble extracts revealed the existence of two molecular forms of vasopressin-receptor complexes (molecular weight = 200,000 and 100,000, respectively). These two molecular forms of vasopressin-receptor complexes can be partially purified and exhibit different properties: (a) The light form is more sensitive to thermal dissociation than is the heavy form. (b) The presence of guanyl nucleotide affects the dissociation rate of only the heavy form of the vasopressin-receptor complex. (c) The light form seems to be convertible to the heavy form by increasing the duration of incubation between the membranes and the tritiated hormone. (d) Guanyl nucleotides affect the distribution of the two molecular forms of the receptor (decrease of the relative amount of the heavy form). These data provide evidence for interaction between vasopressin-receptor complexes (light form) and another protein component, which may be a GTP-binding protein.

Volume 26, Issue 2, pp. 241-247, 09/01/1984
Copyright © 1984 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Granier, S. Terrillon, R. Pascal, H. Demene, M. Bouvier, G. Guillon, and C. Mendre
A Cyclic Peptide Mimicking the Third Intracellular Loop of the V2 Vasopressin Receptor Inhibits Signaling through Its Interaction with Receptor Dimer and G Protein
J. Biol. Chem., December 3, 2004; 279(49): 50904 - 50914.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1984 by the American Society for Pharmacology and Experimental Therapeutics